Price-Driven Insight from (TRDA) for Rule-Based Strategy - Stock Traders DailyYesterday • Google News
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance2025-08-06 • Google News
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Fly 26% But Investors Aren't Buying For Growth - Sahm3 weeks ago • Google News